Literature DB >> 8579542

Injury and general practice in Australia.

R McClure1.   

Abstract

OBJECTIVE: To describe the extent to which general practices are involved in the initial management of injury in Australia.
METHODS: Data were derived from a secondary analysis of the 1989-1990 National Health Survey (NHS); a population-based multi-stage and list sample survey of the Australian population. The study variables used in this analysis included age, sex, country of birth, employment status, place of most recent accident, number of reduced activity days subsequent to injury and where presenting for treatment of the injury.
RESULTS: The ratio of general practice to hospital emergency department attendance for treatment of injury was 1.5:1 (95% confidence limits = 1-2:1). The two groups of patients differed by age, employment status, place of most recent accident but not by sex or country of birth.
CONCLUSION: Results from hospital studies should not be extrapolated to produce community estimates of injury incidence in Australia. General practice should be specifically included in future injury research and control projects.

Entities:  

Mesh:

Year:  1995        PMID: 8579542

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  4 in total

1.  Controlled evaluation of a community based injury prevention program in Australia.

Authors:  J Ozanne-Smith; L Day; V Stathakis; J Sherrard
Journal:  Inj Prev       Date:  2002-03       Impact factor: 2.399

2.  Use of national health interview data to measure the burden of disease and injuries.

Authors:  F J Basterra-Gortari; M Segui-Gomez
Journal:  Inj Prev       Date:  2007-08       Impact factor: 2.399

Review 3.  Measures of injury severity in childhood: a critical overview.

Authors:  T F Beattie; C E Currie; J M Williams; P Wright
Journal:  Inj Prev       Date:  1998-09       Impact factor: 2.399

4.  A profile of patients attending sports medicine clinics.

Authors:  C F Finch; M A Kenihan
Journal:  Br J Sports Med       Date:  2001-08       Impact factor: 13.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.